enow.com Web Search

  1. Ads

    related to: experimental prostate cancer drugs names

Search results

  1. Results from the WOW.Com Content Network
  2. Experimental cancer treatment - Wikipedia

    en.wikipedia.org/wiki/Experimental_cancer_treatment

    Experimental cancer treatments are normally available only to people who participate in formal research programs, which are called clinical trials. Occasionally, a seriously ill person may be able to access an experimental drug through an expanded access program. Some of the treatments have regulatory approval for treating other conditions.

  3. Category:Experimental cancer drugs - Wikipedia

    en.wikipedia.org/wiki/Category:Experimental...

    Pages in category "Experimental cancer drugs" The following 200 pages are in this category, out of approximately 262 total. This list may not reflect recent changes .

  4. Apalutamide - Wikipedia

    en.wikipedia.org/wiki/Apalutamide

    Apalutamide was approved by the Food and Drug Administration in the United States, under the brand name Erleada, for the treatment of non-metastatic castration-resistant prostate cancer in February 2018. [8] [9] It was subsequently approved in Canada, the European Union, and Australia. [42] [6]

  5. Category:Experimental drugs - Wikipedia

    en.wikipedia.org/wiki/Category:Experimental_drugs

    Experimental cancer drugs (262 P) D. Drugs with undisclosed chemical structures (42 P) E. Experimental anti-obesity drugs (5 C, 20 P) Experimental antiviral drugs (45 P)

  6. Seviteronel - Wikipedia

    en.wikipedia.org/wiki/Seviteronel

    Seviteronel (developmental codes VT-464 and, formerly, INO-464) is an experimental cancer medication which is under development by Viamet Pharmaceuticals and Innocrin Pharmaceuticals for the treatment of prostate cancer and breast cancer. [1]

  7. Zibotentan - Wikipedia

    en.wikipedia.org/wiki/Zibotentan

    Zibotentan (INN; development code ZD4054) is an experimental anti-cancer drug candidate in development by AstraZeneca. [1] It is an endothelin receptor antagonist. [2] Zibotentan was granted fast track status for the treatment of prostate cancer by the FDA. It failed a phase III clinical trial for prostate cancer, [3] but other trials are ...

  1. Ads

    related to: experimental prostate cancer drugs names